Drug ID: | NPD7566 |
Drug Name: | REC-15-2739 |
Molecular Formula: | C31H33N3O4 |
Canonical SMILES: | COc1ccccc1N1CCN(CC1)CCCN=C(c1cccc2c1oc(c1ccccc1)c(c2=O)C)O |
Standard InCHI: | InChI=1S/C31H33N3O4/c1-22-28(35)24-12-8-13-25(30(24)38-29(22)23-10-4-3-5-11-23)31(36)32-16-9-17-33-18-20-34(21-19-33)26-14-6-7-15-27(26)37-2/h3-8,10-15H,9,16-21H2,1-2H3,(H,32,36) |
Standard InCHIKey: | DUCNHKDCVVSJLG-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNC004934; DIB011542 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 148842 |
ChEBI | |
CAS Number |
Molecular Weight | 511.25 |
ALogP | -0.5001 |
MLogP | 4.1 |
XLogP | 6.668 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 11 |
TPSA | 74.6 |
RO5 Violation | 1 |